ATE353649T1 - Substituierte 4-phenyl-4-(1h-imidazol-2-yl)- piperidinderivate und deren verwendung als selektive nicht-peptidische delta-opioid- agonisten mit antidepressiver und angstlösender aktivität - Google Patents

Substituierte 4-phenyl-4-(1h-imidazol-2-yl)- piperidinderivate und deren verwendung als selektive nicht-peptidische delta-opioid- agonisten mit antidepressiver und angstlösender aktivität

Info

Publication number
ATE353649T1
ATE353649T1 AT04726520T AT04726520T ATE353649T1 AT E353649 T1 ATE353649 T1 AT E353649T1 AT 04726520 T AT04726520 T AT 04726520T AT 04726520 T AT04726520 T AT 04726520T AT E353649 T1 ATE353649 T1 AT E353649T1
Authority
AT
Austria
Prior art keywords
anxiology
antidepressant
imidazole
phenyl
substituted
Prior art date
Application number
AT04726520T
Other languages
German (de)
English (en)
Inventor
Thomas Horst Wolfgang Steckler
Frans Eduard Janssen Janssens
Joseph Elisabeth Leenaerts
Francisco J Fernandez-Gadea
Antonio Gomez-Sanchez
Theo Frans Meert
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE353649T1 publication Critical patent/ATE353649T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT04726520T 2003-04-11 2004-04-08 Substituierte 4-phenyl-4-(1h-imidazol-2-yl)- piperidinderivate und deren verwendung als selektive nicht-peptidische delta-opioid- agonisten mit antidepressiver und angstlösender aktivität ATE353649T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP0303879 2003-04-11

Publications (1)

Publication Number Publication Date
ATE353649T1 true ATE353649T1 (de) 2007-03-15

Family

ID=33154992

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04726520T ATE353649T1 (de) 2003-04-11 2004-04-08 Substituierte 4-phenyl-4-(1h-imidazol-2-yl)- piperidinderivate und deren verwendung als selektive nicht-peptidische delta-opioid- agonisten mit antidepressiver und angstlösender aktivität

Country Status (12)

Country Link
US (1) US20060287345A1 (https=)
EP (1) EP1615644B1 (https=)
JP (1) JP2006522775A (https=)
AR (1) AR044010A1 (https=)
AT (1) ATE353649T1 (https=)
AU (1) AU2004228960A1 (https=)
CA (1) CA2521186A1 (https=)
CL (1) CL2004000754A1 (https=)
DE (1) DE602004004771T2 (https=)
ES (1) ES2282858T3 (https=)
TW (1) TW200509913A (https=)
WO (1) WO2004089372A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2149370A1 (en) 2008-07-31 2010-02-03 Neuroscienze Pharmaness S.C. A R.L. Diazabicyclic compounds and microemulsions thereof
IT1390848B1 (it) 2008-07-31 2011-10-19 Neuroscienze Pharmaness S C A R L Composti farmaceutici
JP2011030565A (ja) * 2009-07-06 2011-02-17 Yokohama City Univ 社会的隔離モデル動物
IT1396951B1 (it) 2009-12-18 2012-12-20 Neuroscienze Pharmaness S C A R L Composti farmaceutici
ES2770978T3 (es) * 2013-05-24 2020-07-06 Alkermes Pharma Ireland Ltd Análogos de morfanos y morfinanos y métodos de uso
CN113292558A (zh) 2015-03-17 2021-08-24 日本化学药品株式会社 吗啡喃衍生物
WO2018030382A1 (ja) 2016-08-09 2018-02-15 国立大学法人 筑波大学 モルヒナン誘導体
WO2018052114A1 (ja) 2016-09-16 2018-03-22 国立大学法人 筑波大学 モルヒナン誘導体のオピオイドδ受容体アゴニスト関連疾患の治療のための使用
RS66290B1 (sr) 2018-05-01 2025-01-31 Merck Sharp & Dohme Llc Spiropiperidin alosterični modulatori nikotinskih acetiholinskih receptora
US20230141198A1 (en) 2019-11-22 2023-05-11 The Kitasato Institute Pyrazolomorphinan derivative
AU2022225712A1 (en) 2021-02-26 2023-09-07 Nippon Chemiphar Co., Ltd. Pharmaceutical composition for treatment or prevention of stress-related disorders
AU2022245394A1 (en) * 2021-03-26 2023-10-12 Px Ing, Llc The use of paraxanthine to reduce exercise-induced mental fatigue

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354863A (en) * 1992-01-21 1994-10-11 G. D. Searle & Co. Opioid agonist compounds
DE19805370A1 (de) * 1997-03-14 1998-09-17 Gruenenthal Gmbh Substituierte Aminoverbindungen und ihre Verwendung als analgetisch wirksame Substanzen
HN1999000149A (es) * 1998-09-09 2000-01-12 Pfizer Prod Inc Derivados de 4,4-biarilpiperidina
EP1038872A1 (en) * 1999-02-22 2000-09-27 Pfizer Products Inc. 4-Phenyl-4-heteroarylpiperdine derivatives as opioid receptor ligands
DE19939044A1 (de) * 1999-08-18 2001-03-15 Gruenenthal Gmbh Verwendung von Morphinanderivaten als Arzneimittel
SE0101767D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
NZ531733A (en) * 2001-10-15 2006-04-28 Janssen Pharmaceutica Nv Substituted 4-phenyl-4-[1H-imidazol-2-YL]- piperidine derivatives for reducing ischaemic damage
BR0213327A (pt) * 2001-10-15 2004-10-13 Janssen Pharmaceutica Nv Derivados de 4-fenil-4-[1h-imidazol-2-il]-piperidina substituìdos e sua aplicação como agonistas de delta opióides não-peptìdicos seletivos

Also Published As

Publication number Publication date
EP1615644A1 (en) 2006-01-18
JP2006522775A (ja) 2006-10-05
DE602004004771T2 (de) 2007-12-06
CA2521186A1 (en) 2004-10-21
DE602004004771D1 (de) 2007-03-29
AU2004228960A1 (en) 2004-10-21
WO2004089372A1 (en) 2004-10-21
ES2282858T3 (es) 2007-10-16
CL2004000754A1 (es) 2005-02-25
US20060287345A1 (en) 2006-12-21
TW200509913A (en) 2005-03-16
EP1615644B1 (en) 2007-02-14
AR044010A1 (es) 2005-08-24

Similar Documents

Publication Publication Date Title
ATE426597T1 (de) Benzamidderivate und deren verwendung als glucokinaseaktivierende mittel
ATE395339T1 (de) Biphenylderivate und deren verwendung als fungizide
MA28512B1 (fr) Derive heterocyclique accole, composition medicamenteuse en contenant, et son utilisation medicamenteuse
ATE530517T1 (de) Nitrilverbindung und deren verwendung bei der schädlingsbekämpfung
DK1558578T3 (da) Nye Alkynforbindelser med MCH-antagonistisk virkning og lægemiddel indeholdende disse forbindelser.
ATE346056T1 (de) Substituierte phenylacetamide und deren verwendung als glucokinaseaktivatoren
ATE341543T1 (de) Pyridinoylpiperidine als 5-ht1f agonisten
NO20033188D0 (no) Lastcelle-sensor for boremekanikk
ATE461191T1 (de) N-substituierte 2-oxodihydropyridinderivate als npy antagonisten
DE602004021037D1 (de) Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren
DE602006016303D1 (de) 3,4-dihydro-2H-benzoÄ1,4Üoxazin- und 3,4-dihydro-2H-benzoÄ1,4Üthiazin-VERBINDUNGEN ALS ALPHA2C-ADRENOREZEPTOR-ANTAGONISTEN
DE602005023639D1 (de) Chinuclidinderivate und deren verwendung als muscarin-m3-rezeptor-antagonisten
DE602005011593D1 (de) Substituierte diazaspiroä5.5üundecanderivate und deren verwendung als neurokininantagonisten
DE502004004173D1 (de) Silber-legierung und deren Verwendung
ATE353649T1 (de) Substituierte 4-phenyl-4-(1h-imidazol-2-yl)- piperidinderivate und deren verwendung als selektive nicht-peptidische delta-opioid- agonisten mit antidepressiver und angstlösender aktivität
DE50308015D1 (de) Benzothiophen-, benzofuran- und indolharnstoffe und deren verwendung als alpha7-achr agonisten
ATE487707T1 (de) (6-flu0r-benz0äl, 3üdioxolyl)-morpholin-4-yl- methanone und deren verwendung als cbl-liganden
ATE432282T1 (de) 2-alkinyl- und 2-alkenyl-pyrazolo-ä4,3-eü -1,2,4- triazolo-ä1,5-cü -pyrimidinadenosin a2a rezeptorantagonisten
DK1675852T3 (da) Heterocykliske 7-amino-alkylidenyl-quinoloner og -naphthyridoner
DE602005007002D1 (de) Substituierte 4-alkyl- und 4-alkanoylpiperidinderivate und deren verwendung als neurokininantagonisten
AT500356A3 (de) Montagevorrichtung zum setzen von einzelnen gegenständen in eine aufnahme
ATE538093T1 (de) Substituierte 2-carbonylamino-6- piperidinaminopyridine und substituierte 1- carbonylamino-3-piperidinaminobenzole als 5-ht1f- agonisten
NO20044330L (no) Heterosykliske amider med alfa-4 intergrin-antagonistaktivitet
DE602006019861D1 (de) Säule und kassettensäule unter verwendung davon
DE502005007760D1 (de) Schneidelement, schneidenträger und hohlbohrer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties